You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Off-the-shelf (T cells)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

Not yet recruiting
  • Acute Myeloid Leukaemia
  • (no location specified)
Feb 2, 2023

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

CD19-positive Relapsed or Refractory B-cell Malignancies Trial in Hefei (UTAA09 cells for infusion, Fludarabine,

Not yet recruiting
  • CD19-positive Relapsed or Refractory B-cell Malignancies
  • UTAA09 cells for infusion
  • +2 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of USTC (AnHui Provincial Hospital
Oct 13, 2023

Movement Disorder Symptoms WithMobile Medical App on

Active, not recruiting
  • Parkinson Disease
  • Monitoring Device
  • Elkridge, Maryland
    Parkinson's & Movement Disorders Center of Maryland
Dec 27, 2022

Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)

Active, not recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
Feb 25, 2022

Covid19 Trial (KDS-1000, Placebo)

Withdrawn
  • Covid19
  • KDS-1000
  • Placebo
  • (no location specified)
Aug 24, 2021

Severe COVID-19 Disease Trial in Hackensack (RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo)

Terminated
  • Severe COVID-19 Disease
  • RAPA-501-Allo off-the-shelf Therapy of COVID-19
  • Placebo
  • Hackensack, New Jersey
    Hackensack University Medical Center
Nov 3, 2021

Off-the-shelf Single REnal Scalloped sTent-graft for HOstile

Recruiting
  • Abdominal Aortic Aneurysm
  • Endovascular Aortic Repair (EVAR)
  • Baggiovara, Modena, Italy
    AOU di Modena
Jan 30, 2023

Neuropathy (Disorder) Trial in France (Phase A1, Phase B1, Phase A2)

Recruiting
  • Neuropathy (Disorder)
  • Phase A1
  • +3 more
  • Lille, France
  • +3 more
Apr 26, 2022

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Recruiting
  • Acute Myeloid Leukemia
  • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

B Cell Malignancies Trial in Beijing, Shenzhen, Haikou (Universal CD19-specific CAR gene-engineered T cells)

Recruiting
  • B Cell Malignancies
  • Universal CD19-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Post Partum Lumbopelvic Pain Trial (Standard core stability exercise program, Off-the-shelf virtual reality system)

Not yet recruiting
  • Post Partum Lumbopelvic Pain
  • Standard core stability exercise program
  • Off-the-shelf virtual reality system
  • (no location specified)
Jun 19, 2023

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • +3 more
  • Universal CD7-specific CAR gene-engineered T cells
  • Beijing, Beijing, China
  • +2 more
Aug 17, 2023

Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

Recruiting
  • Pancreatic Cancer
  • TCR-T Cells Injection（GB3010 Cells Injection）
  • ShangHai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

TINO: T Cells in the Nose of Older Adults

Recruiting
  • Respiratory Tract Infections
  • Aging
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Center
    Sep 8, 2023

    Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid

    Recruiting
    • Allogeneic Stem Cell Transplant Recipient
    • +3 more
    • Cytarabine Hydrochloride
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 7, 2022

    Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • Metabolically Armed CD19 CAR-T cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Nov 1, 2023

    COVID-19 Trial in Chongqing (NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells)

    Recruiting
    • COVID-19
    • NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells
    • Chongqing, China
      Chongqing Public Health Medical Center
    Nov 16, 2020

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    Myasthenia Gravis Trial in Hangzhou (CD19 CAR-T cells injection)

    Recruiting
    • Myasthenia Gravis
    • CD19 CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 12, 2023

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023